AFFLUENT MEDICAL |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.705 EUR | -0.29% |
|
-3.12% | -7.59% |
| 04-25 | Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-13 | AFFLUENT MEDICAL : Invest Securities reiterates its opinion | CF |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 56.5 | 56.5 | - |
| Enterprise Value (EV) 2 | 62.92 | 86.07 | 104.5 |
| P/E ratio | -3.03 x | -3.2 x | -1.95 x |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | -4.52 x | -5.66 x | -3.86 x |
| EV / FCF | -4.91 x | -5.02 x | -3.84 x |
| FCF Yield | -20.4% | -19.9% | -26.1% |
| Price to Book | 1.8 x | 3.64 x | - |
| Nbr of stocks (in thousands) | 30,899 | 30,899 | - |
| Reference price 3 | 1.710 | 1.710 | 1.710 |
| Announcement Date | 24-04-25 | - | - |
1EUR in Million2USD in Million3EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | - | - | - |
| EBITDA 1 | - | -13.91 | -15.21 | -27.12 |
| EBIT 1 | - | -16.49 | -17.72 | -29 |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) 1 | -16.79 | -15.8 | -18.15 | -39.71 |
| Net income 1 | -16.61 | -15.65 | -19.16 | -29.93 |
| Net margin | - | - | - | - |
| EPS 2 | - | -0.5650 | -0.5350 | -0.8750 |
| Free Cash Flow 1 | - | -13.69 | -17.13 | -27.24 |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 23-03-30 | 24-04-25 | - | - |
1USD in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt 1 | - | 10.7 | 29.6 | 48 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.8213 x | -1.944 x | -1.772 x |
| Free Cash Flow 1 | - | -13.7 | -17.1 | -27.2 |
| ROE (net income / shareholders' equity) | - | -46.7% | -106% | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 2 | - | 0.9500 | 0.4700 | - |
| Cash Flow per Share 2 | - | -0.5500 | -0.4800 | -1.100 |
| Capex 1 | - | 0.07 | 2.25 | 1.61 |
| Capex / Sales | - | - | - | - |
| Announcement Date | 23-03-30 | 24-04-25 | - | - |
1USD in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.71
EUR
Average target price
3.367
EUR
Spread / Average Target
+96.88%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.59% | 56.43M | |
| +73.09% | 12.37B | |
| -18.39% | 7.96B | |
| +14.33% | 7.09B | |
| +3.83% | 5.83B | |
| +11.77% | 5.35B | |
| +29.65% | 4.63B | |
| -17.74% | 4B | |
| -35.92% | 2.41B | |
| +2.72% | 2B |
- Stock Market
- Equities
- AFME Stock
- Financials Affluent Medical
